Ministry of Health ServicesGoverment of British Columbia
Pharmacare Program
| Home | SA Criteria | SA Forms | RDP | LCA |
Dihydropyridine Calcium Channel Blocker Drugs - Special Authority Criteria

Generic Name / Strength / Form
nicardipine

Criteria Approval Period
1. Treatment failure or intolerance to felodipine.

OR

2. Co-existing disease, e.g., diabetes, asthma or heart disease.

Indefinite

Practitioner Exemptions

  • Nephrologists
  • Cardiologists
  • Internists specializing in cardiology

Special Notes

  • None

Online Form
Click on the link to complete a special authority request form.

PDF Format

Some documents on this Web site are in PDF format and require a PDF reader. If you do not have Adobe Acrobat Reader Version 7.0 or the most recent version of another PDF reader, you can download Adobe Acrobat Reader by selecting the 'Get Acrobat Reader' icon. Get Acrobat Reader Icon

Last Revised: June 21, 2006

blank
    space for alignment
Go to TopGo to CopyrightGo to DisclaimerGo to Privacy StatementGo to Feedback Form
blank space for alignment blank space for alignment blank
    space for alignment blank space for alignment blank space for alignment blank space for alignment